148310 20260217205540.0 doi 10.17235/reed.2024.10764/2024 sideral 141724 ART-2024-141724 eng Gomollón, Fernando Universidad de Zaragoza (orcid)0000-0003-0076-3529 New treatments in inflammatory bowel disease - A thrilling time ahead 2024 Access copy available to the general public Unrestricted Except for some surgical techniques, up to 1940 the clinical course of inflammatory bowel disease was determined by its own natural history: most medical interventions even worsened prognosis. The empyrical introduction of salazopyrine early in the 1940s, pioneered by Nanna Svartz in Sweden, was followed relatively soon by the incorporation of corticosteroids during the 1950s. However, it took both a long time to reach patients, and quality scientific evidence to better establish their indications built up very slowly. info:eu-repo/semantics/openAccess by-nc-nd https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es 4.0 2024 GASTROENTEROLOGY & HEPATOLOGY 36 / 148 = 0.243 2024 Q1 T1 0.284 2024 Medicine (miscellaneous) 2024 Q3 Gastroenterology 2024 Q3 1.6 2024 info:eu-repo/semantics/other info:eu-repo/semantics/publishedVersion 1007 610 Universidad de Zaragoza Dpto. Medicina, Psiqu. y Derm. Area Medicina 116, 12 (2024), 657-660 Rev. esp. enferm. dig. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS 1130-0108 641225 http://zaguan.unizar.es/record/148310/files/texto_completo.pdf Versión publicada 3491229 http://zaguan.unizar.es/record/148310/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:148310 articulos driver 2026-02-17-20:36:00 ARTICLE